Cleared Traditional

K103223 - HIGHLY CROSS-LINKED VITAMIN E UHMWPE TIBIAL INSERTS (FDA 510(k) Clearance)

Dec 2010
Decision
50d
Days
Class 2
Risk

K103223 is an FDA 510(k) clearance for the HIGHLY CROSS-LINKED VITAMIN E UHMWPE TIBIAL INSERTS. This device is classified as a Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer + Additive/metal/polymer + Additive (Class II - Special Controls, product code OIY).

Submitted by Encore Medical, L.P. (Austin, US). The FDA issued a Cleared decision on December 21, 2010, 50 days after receiving the submission on November 1, 2010.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3560. Indicated For: 1. Painful And Disabled Knee Joint Resulting From Osteoarthritis, Rheumatoid Arthritis, Traumatic Arthritis Where One Or More Compartments Are Involved. 2. Correction Of Varus, Valgus, Or Posttraumatic Deformity. 3. Correction Or Revision Of Unsuccessful Osteotomy, Arthrodesis, Or Failure Of Previous Joint Replacement Procedure. For Cemented Use..

Submission Details

510(k) Number K103223 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 01, 2010
Decision Date December 21, 2010
Days to Decision 50 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code OIY — Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer + Additive/metal/polymer + Additive
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3560
Definition Indicated For: 1. Painful And Disabled Knee Joint Resulting From Osteoarthritis, Rheumatoid Arthritis, Traumatic Arthritis Where One Or More Compartments Are Involved. 2. Correction Of Varus, Valgus, Or Posttraumatic Deformity. 3. Correction Or Revision Of Unsuccessful Osteotomy, Arthrodesis, Or Failure Of Previous Joint Replacement Procedure. For Cemented Use.